Insider · CIK 0001932527

Chambers Michael Andrew

Reports to the SEC for 1 company · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001932527

Forms 4 and 5

Insider transactions

26 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-04	SRPTSarepta Therapeutics, Inc.A Award	Director	AAward	+16.9K sh	—	—	27,535
2025-12-18	SRPTSarepta Therapeutics, Inc. · Convertible Senior NotesD Disposition to Issuer	Director	DDisposition to Issuer	—	—	—	—
2025-12-18	SRPTSarepta Therapeutics, Inc. · Convertible Senior NotesA Award	Director	AAward	—	—	—	—
2025-03-10	SRPTSarepta Therapeutics, Inc.A Award	Director	AAward	+2,383 sh	—	—	10,660
2025-03-10	SRPTSarepta Therapeutics, Inc. · Stock Options (right to buy)A Award	Director	AAward	+4,792 sh	—	—	4,792
2024-08-16	SRPTSarepta Therapeutics, Inc.P Purchase	Director	PPurchase	+13.1K sh	$133.07	+$1.74M	260,102
2024-08-16	SRPTSarepta Therapeutics, Inc.P Purchase	Director	PPurchase	+18.3K sh	$134.06	+$2.45M	278,386
2024-08-16	SRPTSarepta Therapeutics, Inc.P Purchase	Director	PPurchase	+5,648 sh	$134.66	+$761K	284,034
2024-03-01	SRPTSarepta Therapeutics, Inc.A Award	Director	AAward	+1,846 sh	—	—	8,277
2024-03-01	SRPTSarepta Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+3,679 sh	—	—	3,679
2023-08-14	SRPTSarepta Therapeutics, Inc.P Purchase	Director	PPurchase	+5,947 sh	$109.19	+$649K	242,964
2023-08-14	SRPTSarepta Therapeutics, Inc.P Purchase	Director	PPurchase	+4,032 sh	$109.89	+$443K	246,996
2023-08-11	SRPTSarepta Therapeutics, Inc.P Purchase	Director	PPurchase	+23.7K sh	$108.05	+$2.56M	237,017
2023-08-10	SRPTSarepta Therapeutics, Inc.P Purchase	Director	PPurchase	+2,206 sh	$104.67	+$231K	180,670
2023-08-10	SRPTSarepta Therapeutics, Inc.P Purchase	Director	PPurchase	+1,091 sh	$105.90	+$116K	181,761
2023-08-10	SRPTSarepta Therapeutics, Inc.P Purchase	Director	PPurchase	+31.6K sh	$106.26	+$3.35M	213,331
2023-03-06	SRPTSarepta Therapeutics, Inc.A Award	Director	AAward	+1,523 sh	—	—	6,431
2023-03-06	SRPTSarepta Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+3,257 sh	—	—	3,257
2022-09-14	SRPTSarepta Therapeutics, Inc.P Purchase	Director	PPurchase	+20.7K sh	$103.87	+$2.15M	71,822
2022-09-14	SRPTSarepta Therapeutics, Inc.P Purchase	Director	PPurchase	+30.1K sh	$104.67	+$3.15M	101,928
2022-09-14	SRPTSarepta Therapeutics, Inc.P Purchase	Director	PPurchase	+6,250 sh	$105.16	+$657K	108,178
2022-09-13	SRPTSarepta Therapeutics, Inc. · Convertible Senior NotesA Award	Director	AAward	—	$20000000.00	—	—
2022-08-19	SRPTSarepta Therapeutics, Inc.P Purchase	Director	PPurchase	+40.1K sh	$108.20	+$4.34M	45,018
2022-08-19	SRPTSarepta Therapeutics, Inc.P Purchase	Director	PPurchase	+6,060 sh	$108.80	+$659K	51,078
2022-06-02	SRPTSarepta Therapeutics, Inc.A Award	Director	AAward	+4,908 sh	—	—	4,908
2022-06-02	SRPTSarepta Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+8,329 sh	—	—	8,329

Recent filings

Accepted (ET)
Jun 54
Chambers Michael Andrew0001193125-26-260246
SEC(opens sec.gov)
Dec 194
Chambers Michael Andrew0001193125-25-326980
SEC(opens sec.gov)
Mar 114
Chambers Michael Andrew0000950170-25-037531
SEC(opens sec.gov)
Aug 204
Chambers Michael Andrew0000950170-24-098859
SEC(opens sec.gov)
Mar 54
Chambers Michael Andrew0000950170-24-026613
SEC(opens sec.gov)
Aug 154
Chambers Michael Andrew0001209191-23-045766
SEC(opens sec.gov)
Aug 144
Chambers Michael Andrew0001209191-23-045498
SEC(opens sec.gov)
Aug 114
Chambers Michael Andrew0001209191-23-045366
SEC(opens sec.gov)
Mar 84
Chambers Michael Andrew0001209191-23-017406
SEC(opens sec.gov)
Sep 154
Chambers Michael Andrew0001209191-22-050002
SEC(opens sec.gov)

Companies

Sarepta Therapeutics, Inc.DirectorSRPT

Address

215 FIRST STREET SUITE 415

CAMBRIDGE, MA, 02142